Morning Market Gainers By: Benzinga via Benzinga March 26, 2015 at 09:42 AM EDT Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) shares jumped 39.93% to $8.06 on positive Phase 2 liver treatment results. Magal ... Read More >> Related Stocks: Accenture Plc Conatus Pharmaceutic Five Below Inc Lululemon Athletica Red Hat The Magnificent Seven ETF Transglobe Energy Cp